# Rockwell Medical stock: Q3 sales rise as guidance is withdrawn

> Rockwell Medical reported Q3 2026 net sales up 20% to $19.1 million but a wider net loss, and withdrew its 2026 guidance as it advances the proposed Vantive transaction.

- Date: 2026-11-19 · published 2026-11-20T18:15:54.412Z
- Category: market · region US · magnitude low
- Page: https://feedsoft.ai/events/110605-rockwell-medical-stock-q3-sales-rise-as-guidance-is-withdrawn
- Commodities: [Sodium Bicarbonate](https://feedsoft.ai/c/NABIC.md)

## Why it matters

This is a medical device company's earnings report with no bearing on feed commodities or their prices.

## Sources

- ad-hoc-news.de: https://www.ad-hoc-news.de/boerse/news/nebenwerte/rockwell-medical-stock-q3-sales-rise-as-guidance-is-withdrawn/70538147

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.
